新聞與事件

  • Help Cochrane Crowd reach 2 million classifications
    Cochrane Crowd, Cochrane’s citizen science platform, is a global community made up of volunteers who are helping to identify the research needed to support informed decision-making about healthcare treatments.Cochrane Crowd has reached almost 2 million individual classifications of reports of randomized controlled trials (RCTs) eligible for...
    2 May 2018
  • VII Croatian Congress of PRM
    The 7th national congress of Croatian Society of Physical and Rehabilitation Medicine (PRM), Croatian Medical Association (CSPRM) was been held in Šibenik, Croatia, 19-22 April 2018. Two round tables - about Quality management in PRM and Cochrane Rehabilitation initiative were held.During the meeting a Memorandum of Understanding between Cochrane...
    2 May 2018
  • World Asthma Day
    World Asthma Day on 1 May  is an annual event on organized by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world.Cochrane Airways works with authors (typically clinicians and researchers) to produce systematic reviews on chronic obstructive pulmonary disease (COPD), bronchiectasis and other lung diseases...
    1 May 2018
  • Cochrane’s Future Publishing and Open Access Arrangements
    Today Cochrane announces important decisions on its future publishing and open access arrangements, part of its commitment of making Cochrane evidence freely and openly accessible to everyone all over the world.Cochrane has agreed improved terms and a two-year extension of its existing publishing agreement with John Wiley & Sons, Limited,...
    30 四月 2018
  • New Cochrane-wide peer review policy
    On Monday 16th April Cochrane published the first Cochrane-wide peer review policy.  In addition to standardising current practice across all of Cochrane’s 53 Review Groups, the introduction of the new policy aims to improve transparency in communication and decision making, consistent with core Cochrane principles, and taking the opportunity to...
    26 四月 2018
  • Stay connected! Sign up for the Cochrane newsletter.
    Cochrane Connect brings you a monthly dose of news, events, and noteworthy Cochrane Reviews - right to your inbox.Get the latest Cochrane news with our monthly newsletter, Cochrane Connect. It rounds up the month's most important Cochrane Reviews and biggest news stories, so you can stay up to date with the latest Cochrane information.  Each...
    26 四月 2018
  • Opportunity for some keen tweeters to come to the Cochrane Colloquium 2018
    Announcing a great opportunity for some keen tweeters to come to the Cochrane Colloquium 2018 (with free registration, accommodation and a travel bursary) as part of the #BeyondTheRoom team.We’re really excited about this. Not ‘excited’ as in “we know we need to appear enthusiastic about this and this is an easy word to reach for” kind of excited...
    25 四月 2018
  • Featured Review: Uterotonic agents for preventing postpartum haemorrhage
    New evidence on the best drugs to prevent postpartum haemorrhage point away from Oxytocin – the standard drug currently used to prevent this condition.Bleeding after birth is the most common reason why mothers die in childbirth worldwide.Includes data from 88,000 women across 140 trials.The review found that ergometrine plus oxytocin, misoprostol...
    25 四月 2018
  • Stipend applications closing  7 May 2018
    Stipend applications closing Monday 7 May 2018A number of stipends and bursaries are available to help consumers and other attendees based in developing countries to attend Cochrane Colloquium Edinburgh 2018.The stipends (funding you can apply for, if eligible) are to help cover registration, travel, accommodation, and other expenses associated...
    24 四月 2018
  • Featured Review: First-line drugs for hypertension
    Thiazides best first choice for hypertensionHigh blood pressure or hypertension can increase the risk of heart attacks and stroke. One of the most important decisions in treating people with elevated blood pressure is what drug class to use first. This decision has important consequences in terms of health outcomes and cost.The Cochrane...
    23 四月 2018

Subscribe to 新聞與事件